Gevo, Inc. (NASDAQ: GEVO) will participate in a virtual investor presentation and live Q&A, featuring Gevo’s CEO, Dr. Patrick Gruber, and Gevo’s Vice President of Corporate Development, Eric Frey, ...
Gevo (NASDAQ:GEVO – Get Free Report)‘s stock had its “buy” rating reissued by research analysts at HC Wainwright in a research note issued to investors on Tuesday,Benzinga reports. They presently have ...
Eli Lilly stock rose Thursday despite lighter-than-expected sales of its weight-loss and diabetes drugs Zepbound and Mounjaro ...
Drugmaker Bristol Myers Squibb has been a standout among its big pharma peers over the past six months, scoring a share-price ...
Palantir Technologies (NASDAQ:PLTR – Get Free Report) had its price objective increased by research analysts at DA Davidson from $47.00 to $105.00 in a note issued to investors on Tuesday,Benzinga ...